Tobin RP, Cogswell DT, Cates VM, Davis DM, et al. Targeting MDSC differentiation using ATRA: a phase I/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma. Clin Cancer Res 2022 Nov 15. pii: 710714. doi: 10.1158/1078-0432.CCR-22-2495.
PMID: 36378549